Therapeutic DNAzymes: From Structure Design to Clinical Applications

dc.contributor.authorYan Jiaqi
dc.contributor.authorRan Meixin
dc.contributor.authorShen Xian
dc.contributor.authorZhang Hongbo
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.contributor.organization-code2607100
dc.converis.publication-id179996772
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/179996772
dc.date.accessioned2025-08-28T00:13:12Z
dc.date.available2025-08-28T00:13:12Z
dc.description.abstract<p>Therapeutic DNAzymes have unceasingly intrigued the scientific community owing to their prosperous gene regulation capability. The efficacy of DNAzymes against many types of diseases has been extensively studied for over two decades. However, the high expectations for DNAzymes are still not translated to the clinic because of their low effectiveness in vivo. Over the last five years, several aspects have been considered to optimize DNAzyme-integrated therapeutics, including structural stability, mechanism exploration, cell internalization rate, cofactor activation, and off-target effects. Hence, this review first discusses the early monotherapy and structural design of DNAzymes. Subsequently, the latest modes of action are reviewed, followed by an elaboration on structural stabilization strategies considering the catalytic core and substrate-binding arms. DNAzyme-based synergistic therapy is then examined, highlighting responsive carrier construction, synergistic effects, the latest discovered advanced functions, and off-target concerns. Beyond this, key clinical advances in DNAzyme-based therapy are elucidated by showcasing clinical progress. Finally, future trends and development challenges for DNAzyme-powered therapeutics in the coming years are discussed in detail.<br></p>
dc.identifier.eissn1521-4095
dc.identifier.jour-issn0935-9648
dc.identifier.olddbid205405
dc.identifier.oldhandle10024/188432
dc.identifier.urihttps://www.utupub.fi/handle/11111/54331
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1002/adma.202300374
dc.identifier.urnURN:NBN:fi-fe2025082786982
dc.language.isoen
dc.okm.affiliatedauthorRan, Meixin
dc.okm.affiliatedauthorZhang, Hongbo
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherWILEY-V C H VERLAG GMBH
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.relation.doi10.1002/adma.202300374
dc.relation.ispartofjournalAdvanced Materials
dc.source.identifierhttps://www.utupub.fi/handle/10024/188432
dc.titleTherapeutic DNAzymes: From Structure Design to Clinical Applications
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Advanced Materials - 2023 - Yan - Therapeutic DNAzymes From Structure Design to Clinical Applications.pdf
Size:
10.08 MB
Format:
Adobe Portable Document Format